AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 09:30 am Sale | 2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | AVORO CAPITAL ADVISORS LLC | 0 0.000% | -695,000 (Position Closed) | Filing |
| 2022-02-11 10:01 am Sale | 2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | AVORO CAPITAL ADVISORS LLC | 695,000 7.100% | -105,000 (-13.12%) | Filing |
| 2021-02-12 08:00 am Purchase | 2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | AVORO CAPITAL ADVISORS LLC | 800,000 8.200% | 275,000 (+52.38%) | Filing |